出生前・新生児遺伝子検査の世界市場レポート 2025年

出生前・新生児遺伝子検査の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR12.1％で120億4,000万米ドルに成長します。予測期間の成長は、遺伝子検査パネルの拡大、妊産婦の健康意識の高まり、出生前・新生児スクリーニングのガイドライン、希少疾患への注目の高まり、倫理的・規制的配慮などに起因すると考えられます。予測期間における主な動向には、非侵襲的出生前検査（NIPT）、ゲノムシークエンシング（WGS）および全エクソームシークエンシング、人工知能（AI）の統合、着床前遺伝学的検査（PGT）、消費者直接遺伝子検査などがあります。

出生前検査や新生児遺伝子スクリーニングに対する政府の取り組みや支援は、当面の出生前・新生児遺伝子検査市場の拡大を促進すると予想されます。このような取り組みには、特定の問題に対処したり市民の幸福を増進したりするために、さまざまなレベルの政府機関が導入する特定の行動、プログラム、政策が含まれます。政府は、出生前・新生児遺伝子検査プログラムを提唱し支援することによって、妊娠中や出生直後の胎児の遺伝子異常や状態の特定に貢献しています。2022年6月、オーストラリア政府がニューサウスウェールズ州（NSW州）の新生児スクリーニング・プログラムに毎年130万米ドルを拠出したことがその一例です。この資金により、重症複合免疫不全症（SCID）と脊髄性筋萎縮症（SMA）の無料検査が促進され、州内のすべての新生児に遺伝子スクリーニングが提供され、年間10万人の新生児のうち、これらの遺伝子疾患を持つ13人の命を救う可能性があります。したがって、出生前および新生児の遺伝子スクリーニングを強化する政府の取り組みが、それぞれの検査市場の成長を後押ししています。

遺伝性疾患の罹患率の上昇は、将来的に出生前・新生児遺伝子検査市場の成長を促進すると予想されます。遺伝子疾患は、個人のDNAや遺伝物質の異常や変異によって引き起こされる病状です。出生前・新生児遺伝子検査は、これらの疾患の早期発見を可能にし、多くの場合、症状が現れる前に発見できるため、ヘルスケアプロバイダーはタイムリーな介入や治療戦略を実施することができます。例えば、2024年5月、米国の公衆衛生機関である疾病対策予防センター（CDC）は、鎌状赤血球症（SCD）は米国で約10万人が罹患していると報告しました。罹患者のうち90％以上が非ヒスパニック系黒人またはアフリカ系アメリカ人であり、ヒスパニック系またはラテン系アメリカ人は推定3％～9％です。このように、遺伝性疾患の有病率の増加が出生前・新生児遺伝子検査市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界出生前・新生児遺伝子検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の出生前・新生児遺伝子検査市場：成長率分析
• 世界の出生前・新生児遺伝子検査市場の実績：規模と成長, 2019-2024
• 世界の出生前・新生児遺伝子検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界出生前・新生児遺伝子検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の出生前・新生児遺伝子検査市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消耗品
• 機器
• 世界の出生前・新生児遺伝子検査市場上映作品、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非侵襲的出生前検査
• 慢性絨毛サンプル採取
• 羊水穿刺
• 母体血清スクリーニング
• その他の上映作品
• 世界の出生前・新生児遺伝子検査市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ダウン症候群
• フェニルケトン尿症
• 嚢胞性線維症
• 鎌状赤血球貧血
• 世界の出生前・新生児遺伝子検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 産科・専門クリニック
• 診断センター
• 世界の出生前・新生児遺伝子検査市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬とアッセイ
• サンプル収集キット
• 検査キット
• 世界の出生前・新生児遺伝子検査市場、楽器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）装置
• シーケンサー
• マイクロアレイアナライザー

第7章 地域別・国別分析

• 世界の出生前・新生児遺伝子検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の出生前・新生児遺伝子検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 出生前・新生児遺伝子検査市場：競合情勢
• 出生前・新生児遺伝子検査市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Danaher Corporation
• Siemens Healthineers AG
• Becton, Dickinson and Company
• Quest Diagnostic Incorporated
• Agilent Technologies Inc.
• Grifols S.A.
• Terumo Corporation
• Illumina Inc.
• PerkinElmer Genomics
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• Qiagen NV
• Werfen S.A.
• DiaSorin S.p.A
• Nova Biomedical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 出生前・新生児遺伝子検査市場2029：新たな機会を提供する国
• 出生前・新生児遺伝子検査市場2029：新たな機会を提供するセグメント
• 出生前・新生児遺伝子検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Prenatal and newborn genetic testing encompasses medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are crucial for detecting and identifying genetic disorders, congenital conditions, or hereditary diseases that may impact the child's health or development.

The primary product types within the prenatal and newborn genetic testing domain include consumables and instruments. Instruments refer to specialized tools or devices designed for specific tasks or measurements, including various genetic analyzers used by healthcare professionals to conduct screenings and tests. Various screening methods include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The tests aim to identify diseases such as Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. These genetic testing products find application across diverse end-users, including hospitals, maternity and specialty clinics, and diagnostic centers.

The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides prenatal and newborn genetic testing market statistics, including prenatal and newborn genetic testing industry global market size, regional shares, competitors with a prenatal and newborn genetic testing market share, detailed prenatal and newborn genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. This prenatal and newborn genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.61 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to improved non-invasive prenatal testing, increased maternal age, government support and healthcare policies, patient demand for early detection.

The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $12.04 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to expanded genetic test panels, increasing maternal health awareness, prenatal and newborn screening guidelines, rising focus on rare diseases, ethical and regulatory considerations. Major trends in the forecast period include non-invasive prenatal testing (NIPT), genome sequencing (WGS) and whole exome sequencing, integration of artificial intelligence (AI), preimplantation genetic testing (PGT), direct-to-consumer genetic testing.

Government initiatives and backing for prenatal testing and newborn genetic screening are anticipated to propel the expansion of the prenatal and newborn genetic testing markets in the foreseeable future. Such initiatives encompass specific actions, programs, or policies introduced by governmental bodies at various levels to address particular issues or promote the well-being of citizens. By advocating for and supporting prenatal and newborn genetic testing programs, governments contribute to the identification of genetic abnormalities or conditions in fetuses during pregnancy or shortly after birth. An illustration of this is seen in the Australian government's allocation of $1.3 million annually to the New South Wales (NSW) newborn screening program in June 2022. This funding facilitated free testing for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), providing genetic screening to all newborns in the state and potentially saving the lives of 13 infants with these genetic disorders among the 100,000 babies born yearly. Hence, government initiatives fortifying prenatal and newborn genetic screening drive the growth of the respective testing markets.

The rising incidence of genetic disorders is anticipated to drive growth in the prenatal and newborn genetic testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's DNA or genetic material. Prenatal and newborn genetic testing enables the early identification of these disorders, often before symptoms appear, allowing healthcare providers to implement timely interventions and treatment strategies. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that sickle cell disease (SCD) affects approximately 100,000 individuals in the United States. Among those affected, over 90% are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Thus, the increasing prevalence of genetic disorders is propelling the growth of the prenatal and newborn genetic testing market.

Leading companies in the prenatal and newborn genetic testing sectors are concentrating on developing innovative screening tests, particularly noninvasive prenatal screening tests, to enhance accessibility and affordability while ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) represents an advanced and secure genetic screening method conducted during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. An instance of this advancement is Juno Diagnostics Inc.'s introduction of Juno Hazel in November 2022. This noninvasive prenatal screening test identifies chromosomal anomalies and offers clinical content using a sample collection kit, eliminating the necessity for phlebotomy and enhancing accessibility. Additionally, the company intends to provide educational resources and personalized genetic counseling support by partnering with healthcare professionals and genetic counselors.

In February 2024, CooperSurgical Inc., a US-based medical equipment manufacturing company, formed a partnership with Fulgent Genetics to enhance its offerings in the prenatal and newborn genetic testing market. This collaboration aims to leverage Fulgent Genetics' expertise in advanced genetic testing solutions, particularly for families using the Cord Blood Registry. Fulgent Genetics Inc. specializes in providing a range of prenatal and newborn genetic testing services, which aligns with CooperSurgical's goals of expanding its portfolio and improving access to critical genetic testing options for expectant families.

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal and newborn genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal And Newborn Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal and newborn genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal and newborn genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal and newborn genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Consumables; Instruments
• 2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
• 3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
• 4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers
• Subsegments:
• 1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits
• 2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers
• Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal And Newborn Genetic Testing Market Characteristics

3. Prenatal And Newborn Genetic Testing Market Trends And Strategies

4. Prenatal And Newborn Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Prenatal And Newborn Genetic Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prenatal And Newborn Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prenatal And Newborn Genetic Testing Market Growth Rate Analysis
• 5.4. Global Prenatal And Newborn Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prenatal And Newborn Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prenatal And Newborn Genetic Testing Total Addressable Market (TAM)

6. Prenatal And Newborn Genetic Testing Market Segmentation

• 6.1. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Instruments
• 6.2. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing
• Chronic Villus Sampling
• Amniocentesis
• Maternal Serum Screening
• Other Screenings
• 6.3. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Down Syndrome
• Phenylketonuria
• Cystic Fibrosis
• Sickle Cell Anemia
• 6.4. Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Maternity And Specialty Clinics
• Diagnostic Centers
• 6.5. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Assays
• Sample Collection Kits
• Test Kits
• 6.6. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR) Machines
• Sequencers
• Microarray Analyzers

7. Prenatal And Newborn Genetic Testing Market Regional And Country Analysis

• 7.1. Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal And Newborn Genetic Testing Market

• 8.1. Asia-Pacific Prenatal And Newborn Genetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal And Newborn Genetic Testing Market

• 9.1. China Prenatal And Newborn Genetic Testing Market Overview
• 9.2. China Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal And Newborn Genetic Testing Market

• 10.1. India Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal And Newborn Genetic Testing Market

• 11.1. Japan Prenatal And Newborn Genetic Testing Market Overview
• 11.2. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal And Newborn Genetic Testing Market

• 12.1. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal And Newborn Genetic Testing Market

• 13.1. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal And Newborn Genetic Testing Market

• 14.1. South Korea Prenatal And Newborn Genetic Testing Market Overview
• 14.2. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal And Newborn Genetic Testing Market

• 15.1. Western Europe Prenatal And Newborn Genetic Testing Market Overview
• 15.2. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal And Newborn Genetic Testing Market

• 16.1. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal And Newborn Genetic Testing Market

• 17.1. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal And Newborn Genetic Testing Market

• 18.1. France Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal And Newborn Genetic Testing Market

• 19.1. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal And Newborn Genetic Testing Market

• 20.1. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal And Newborn Genetic Testing Market

• 21.1. Eastern Europe Prenatal And Newborn Genetic Testing Market Overview
• 21.2. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal And Newborn Genetic Testing Market

• 22.1. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal And Newborn Genetic Testing Market

• 23.1. North America Prenatal And Newborn Genetic Testing Market Overview
• 23.2. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal And Newborn Genetic Testing Market

• 24.1. USA Prenatal And Newborn Genetic Testing Market Overview
• 24.2. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal And Newborn Genetic Testing Market

• 25.1. Canada Prenatal And Newborn Genetic Testing Market Overview
• 25.2. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal And Newborn Genetic Testing Market

• 26.1. South America Prenatal And Newborn Genetic Testing Market Overview
• 26.2. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal And Newborn Genetic Testing Market

• 27.1. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal And Newborn Genetic Testing Market

• 28.1. Middle East Prenatal And Newborn Genetic Testing Market Overview
• 28.2. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal And Newborn Genetic Testing Market

• 29.1. Africa Prenatal And Newborn Genetic Testing Market Overview
• 29.2. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal And Newborn Genetic Testing Market Competitive Landscape And Company Profiles

• 30.1. Prenatal And Newborn Genetic Testing Market Competitive Landscape
• 30.2. Prenatal And Newborn Genetic Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal And Newborn Genetic Testing Market Other Major And Innovative Companies

• 31.1. Danaher Corporation
• 31.2. Siemens Healthineers AG
• 31.3. Becton, Dickinson and Company
• 31.4. Quest Diagnostic Incorporated
• 31.5. Agilent Technologies Inc.
• 31.6. Grifols S.A.
• 31.7. Terumo Corporation
• 31.8. Illumina Inc.
• 31.9. PerkinElmer Genomics
• 31.10. Quidel Corporation
• 31.11. Bio-Rad Laboratories Inc.
• 31.12. Qiagen NV
• 31.13. Werfen S.A.
• 31.14. DiaSorin S.p.A
• 31.15. Nova Biomedical

32. Global Prenatal And Newborn Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market

34. Recent Developments In The Prenatal And Newborn Genetic Testing Market

35. Prenatal And Newborn Genetic Testing Market High Potential Countries, Segments and Strategies

• 35.1 Prenatal And Newborn Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prenatal And Newborn Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prenatal And Newborn Genetic Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer